COMMON STOCK PURCHASE WARRANT AGREEMENTWarrant Agreement • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc.
This Warrant Agreement (this “Agreement”) is dated as of _______________, (the “Issue Date”) and entered into by and between BioRegenx, Inc, a company organized under the laws of the State of Nevada .
AGREEMENTAgreement • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc.
THIS AGREEMENT is entered into this 13th day of May 2015 (the ''Effective Date"), by and between the "VHS Parties" and the "MVHS Parties," as these terms are defined herein.
ContractConvertible Promissory Note • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc. • Tennessee
THIS INSTRUMENT AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT.
SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc. • Tennessee
BioRegenx, Inc. a corporation existing under the laws of the State of Nevada, having a registered office at 7407 Ziegler Road, Chattanooga, Tennessee 37421
DISTRIBUTORSHIP AGREEMENTDistributorship Agreement • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc.
and: Glycocheck B.V, a Dutch company organized under the laws of the Netherlands having a place of business at Oxfordlan 70 NL 6229 EV Maastrictht, The Netherlands (“GLYCOCHECK”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • October 9th, 2024 • Bioregenx, Inc. • Services-computer programming, data processing, etc.
AGREEMENT AND PLAN OF MERGER (this “Merger Agreement”) made and entered into effective December 29, 2022 by and between BioRegenx, Inc., a Nevada corporation (“BioRegenx”) and Findit, Inc., a Nevada corporation (“Findit”).
